Recombinant human chymotrypsin(Wuhan Healthgen Biotech)
重组人糜蛋白酶（武汉禾元生物）
Report date: 2025/01/10 20:00:59
Base Information
Drug NameRecombinant human chymotrypsin(Wuhan Healthgen Biotech)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesWuhan Healthgen Biotechnology Corp
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesWuhan Healthgen Biotechnology Corp
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A